Authors:
OHALLORAN DJ
WIERINGA G
TSATSOULIS A
SHALET SM
Citation: Dj. Ohalloran et al., INCREASED SERUM LIPOPROTEIN(A) CONCENTRATIONS AFTER GROWTH-HORMONE (GH) TREATMENT IN PATIENTS WITH ISOLATED GH DEFICIENCY, Annals of clinical biochemistry, 33, 1996, pp. 330-334
Authors:
HOLMES SJ
WHITEHOUSE RW
ECONOMOU G
OHALLORAN DJ
ADAMS JE
SHALET SM
Citation: Sj. Holmes et al., FURTHER INCREASE IN FOREARM CORTICAL BONE-MINERAL CONTENT AFTER DISCONTINUATION OF GROWTH-HORMONE REPLACEMENT, Clinical endocrinology, 42(1), 1995, pp. 3-7
Citation: Sm. Shalet et Dj. Ohalloran, GROWTH AND ENDOCRINE SEQUELAE FOLLOWING THE TREATMENT OF CHILDHOOD-CANCER, The Endocrinologist, 4(1), 1994, pp. 44-55
Citation: Dj. Ohalloran et Sm. Shalet, A FAMILY PEDIGREE EXHIBITING FEATURES OF BOTH MULTIPLE ENDOCRINE NEOPLASIA TYPE-1 AND MCCUNE-ALBRIGHT SYNDROMES, The Journal of clinical endocrinology and metabolism, 78(3), 1994, pp. 523-525
Authors:
RAZZAQ R
OHALLORAN DJ
BEARDWELL CG
SHALET SM
Citation: R. Razzaq et al., THE EFFECTS OF CV205-502 IN PATIENTS WITH HYPERPROLACTINEMIA INTOLERANT AND OR RESISTANT TO BROMOCRIPTINE, Hormone research, 39(5-6), 1993, pp. 218-222
Authors:
DOBRASHIAN RD
OHALLORAN DJ
HUNT A
BEARDWELL CG
SHALET SM
Citation: Rd. Dobrashian et al., RELATIONSHIPS BETWEEN INSULIN-LIKE GROWTH FACTOR-I LEVELS AND GROWTH-HORMONE CONCENTRATIONS DURING DIURNAL PROFILES AND FOLLOWING ORAL GLUCOSE IN ACROMEGALY, Clinical endocrinology, 38(6), 1993, pp. 589-593
Authors:
OHALLORAN DJ
TSATSOULIS A
WHITEHOUSE RW
HOLMES SJ
ADAMS JE
SHALET SM
Citation: Dj. Ohalloran et al., INCREASED BONE-DENSITY AFTER RECOMBINANT HUMAN GROWTH-HORMONE (GH) THERAPY IN ADULTS WITH ISOLATED GH DEFICIENCY, The Journal of clinical endocrinology and metabolism, 76(5), 1993, pp. 1344-1348